Nicolas-Virelizier E on Muck Rack

Nicolas-Virelizier E

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nicolas-Virelizier

Contact Nicolas-Virelizier, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

|
By Chretien ML, Escoffre-Barbe M, Lauwers-Cances V, Nicolas-Virelizier E
| ncbi.nlm.nih.gov
Clinical Trial doi: 10.1182/blood.2021014635. Affiliations Affiliations 1 Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Toulouse, France. 2 USMR, Centre Hospitalo-universitaire (CHU) de Toulouse, Toulouse, France. 3 Centre Hospitalo-universitaire (CHU) Côte de Nacre, Caen, France. 4 Centre Hospitalo-universitaire (CHU) La Mileterie, INSERM CIC 1402, Poitiers, France.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Nicolas-Virelizier

Contact Nicolas-Virelizier, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified